Artificial Intelligence Models and Tools for the Assessment of Drug–Herb Interactions
Pharmaceuticals,
Journal Year:
2025,
Volume and Issue:
18(3), P. 282 - 282
Published: Feb. 20, 2025
Artificial
intelligence
(AI)
has
emerged
as
a
powerful
tool
in
medical
sciences
that
is
revolutionizing
various
fields
of
drug
research.
AI
algorithms
can
analyze
large-scale
biological
data
and
identify
molecular
targets
pathways
advancing
pharmacological
knowledge.
An
especially
promising
area
the
assessment
interactions.
The
analysis
large
datasets,
such
drugs’
chemical
structure,
properties,
pathways,
known
interaction
patterns,
provide
mechanistic
insights
potential
associations
by
integrating
all
this
complex
information
returning
risks
associated
with
these
In
context,
an
where
may
prove
valuable
underlying
mechanisms
interactions
natural
products
(i.e.,
herbs)
are
used
dietary
supplements.
These
pose
challenging
problem
since
they
mixtures
constituents
diverse
limited
regarding
their
pharmacokinetic
data.
As
use
herbal
supplements
continues
to
grow,
it
becomes
increasingly
important
understand
between
them
conventional
drugs
adverse
reactions.
This
review
will
discuss
approaches
how
be
exploited
providing
prediction
herbs,
exploitation
experimental
validation
or
clinical
utilization.
Language: Английский
Strengthening Drug Safety and Public Health Surveillance in the United States: The Role of Artificial Intelligence in Pharmacovigilance
Eguolo Ann Majekodunmi
No information about this author
Published: Jan. 1, 2025
Language: Английский
Enhancing risk management in hospitals: leveraging artificial intelligence for improved outcomes
Ranieri Guerra
No information about this author
Italian Journal of Medicine,
Journal Year:
2024,
Volume and Issue:
18(2)
Published: April 15, 2024
In
hospital
settings,
effective
risk
management
is
critical
to
ensuring
patient
safety,
regulatory
compliance,
and
operational
effectiveness.
Conventional
approaches
assessment
mitigation
frequently
rely
on
manual
procedures
retroactive
analysis,
which
might
not
be
sufficient
recognize
respond
new
risks
as
they
arise.
This
study
examines
how
artificial
intelligence
(AI)
technologies
can
improve
in
healthcare
facilities,
fortifying
safety
precautions
guidelines
while
improving
the
standard
of
care
overall.
Hospitals
proactively
identify
mitigate
risks,
optimize
resource
allocation,
clinical
outcomes
by
utilizing
AI-driven
predictive
analytics,
natural
language
processing,
machine
learning
algorithms.
The
different
applications
AI
are
discussed
this
paper,
along
with
opportunities,
problems,
suggestions
for
their
use
settings.
Language: Английский
Artificial intelligence-driven patient monitoring for adverse event detection in clinical trials
Sai Bhargavi Vampana,
No information about this author
E. Jayanthi,
No information about this author
D. A. S. G. Mary
No information about this author
et al.
International Journal of Basic & Clinical Pharmacology,
Journal Year:
2024,
Volume and Issue:
13(4), P. 543 - 550
Published: June 25, 2024
Artificial
intelligence
(AI)
keeps
an
eye
on
people
in
clinical
studies
to
find
out
when
bad
things
happen.
This
is
a
big
way
that
AI
changing
healthcare.
It
goes
into
lot
of
detail
about
how
has
changed
this
field
and
stresses
important
it
use
complicated
formulas,
always
keep
things,
follow
the
rules.
These
days,
we
have
tools
like
deep
learning
frameworks,
controlled
unsupervised
models,
others
help
us
faster
more
accurately.
Tracking
real
time
possible
with
early
warning
systems
constant
data
analysis.
helps
make
sure
experiment
done
right
puts
safety
being
tested
first.
AI-driven
tracking
can
only
work
honest
reliable
if
they
rules
set
by
regulatory
bodies
such
as
FDA
EMA.
The
fact
ability
change
medical
research
today,
benefits
making
accurate,
makes
its
problems
even
important.
report
comes
conclusion
research,
better
teamwork,
wider
technologies
are
needed
events
over
time.
Language: Английский